title: Allogeneic hematopoietic stem cell transplantation in the elderly.
abstract: The development of reduced intensity or non-myeloablative conditioning (NST) in preparation for allogeneic stem cell transplantation (SCT) revolutionized the field and led to reconsideration of the dogma of upper age limit that was set up by the transplant centers as an eligibility parameter. Analysis of the literature data showed that NST regimens are associated with decreased transplant related mortality, and graft-versus-host disease, in comparison with standard myeloablative conditioning, in patients above the age of 50-55 years, or in younger patients with significant comorbidities. However we have to mention, that our considerations are based on the retrospective analysis of the literature data, and that well controlled prospective randomized studies are needed in order to definitely assess the role of NST. Comorbidity indices might be proved as the most important parameters for the choice of the most proper regimen for each patient in need and should be included in future trials.
authors.affiliation: Department of Bone Marrow Transplantation & Cancer Immunotherapy, Hadassah-Hebrew University Hospital, Jerusalem 91120, Israel. shapiram@hadassah.org.il
authors.forename: Michael Y
authors.initials: MY
authors.lastname: Shapira
authors.forename: P
authors.initials: P
authors.lastname: Tsirigotis
authors.forename: I B
authors.initials: IB
authors.lastname: Resnick
authors.forename: R
authors.initials: R
authors.lastname: Or
authors.forename: A
authors.initials: A
authors.lastname: Abdul-Hai
authors.forename: S
authors.initials: S
authors.lastname: Slavin
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D015897:Comorbidity; D019337:Hematologic Neoplasms / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods* / Q000401:mortality; D006801:Humans; D008875:Middle Aged; D011379:Prognosis; D019172:Transplantation Conditioning / Q000009:adverse effects / Q000379:methods / Q000401:mortality; D016896:Treatment Outcome